Use of prior authorization and step therapy for drugs used in the treatment of opioid use disorder under medical assistance prohibited.

HF 3444 prohibits Minnesota's medical assistance program (Medicaid) from requiring prior authorization or step therapy for any FDA-approved drug used to treat opioid use disorder. This means Medicaid patients receiving treatment for opioid addiction will not face extra approval steps or forced trials of cheaper alternatives. The bill amends Minnesota Statutes to add a specific exception blocking these requirements for opioid use disorder medications. It directly affects Medicaid patients and the state agency managing drug coverage policies.